PAR 0.00% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-60

  1. 3,769 Posts.
    lightbulb Created with Sketch. 1548
    This was also written in the previous quarterly:

    “Research and development expenditure for the quarter was $21.9m compared to the previous quarter of $16.15m.

    The anticipated spend for Q2 FY24 is expected to be at a lower level to the previous two quarters. ”

    The forecasts are worth the paper they are written on.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.000(0.00%)
Mkt cap ! $85.7M
Open High Low Value Volume
25.0¢ 25.5¢ 24.5¢ $112.3K 450.3K

Buyers (Bids)

No. Vol. Price($)
5 322039 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 46325 3
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.